Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment

BACKGROUND: Panitumumab in combination with chemotherapy was evaluated in two pivotal clinical trials in first- and second-line treatment of metastatic colorectal cancer (mCRC), respectively. This analysis compared the health-related quality of life (HRQoL) of patients with or without panitumumab in...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bennett, L, Zhao, Z, Barber, B, Zhou, X, Peeters, M, Zhang, J, Xu, F, Wiezorek, J, Douillard, J-Y
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2011
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3242525/
https://ncbi.nlm.nih.gov/pubmed/21989186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.409
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares